PERSPECTA

News from every angle

← Back to headlines

JPMorgan Raises Price Target on Xenon Pharmaceuticals (XENE)

JPMorgan has adjusted its price target upwards for Xenon Pharmaceuticals (XENE), reflecting a potentially more optimistic view on the company's future performance.

23 May, 02:31 — 23 May, 02:31
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual97d ago

JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE)

Read full article →

Related Stories

Kevin Warsh gets what every Fed chair hopes for: A bond market that trust his words

14m ago

Fed Chair Warsh Flags Need for More Rate Hikes as Inflation Lingers

47m ago

Klarna CEO Purchases $10 Million in Company Stock

59m ago

Meta Reaches $18 Billion Settlement Mandating Stricter Child Safety Rules

1h ago